News & Notes

  • OTT Event: Save the Date for this Year's Annual Celebration ... View More
  • Emory Product: Obizur for Acquired Haemophilia Receives EU Approval ... View More
  • Emory Start-up:: AKESOgen makes Inc. Magazines list of fastest growing private companies ... View More
  • Emory Sponsored Research: Record $572.4 million in external research funding for 2015 ... View More
  • ORA Changes: Important Changes in OSP Contract Administration ... View More

Featured Innovation

Novel Small Molecule TAK-1 Inhibitors for Cancer Treatment

Huw Davies, PhD

Emory’s Huw Davies, PhD, a fellow of the National Academy of Inventors (NAI), is a synthetic chemist who is currently working on this problem. Davies collaborates with biologists to create small novel compounds that inhibit certain proteins involved in normal body functions. Although these proteins are vital for proper cell function, if overexpresse d, they may also lead to cancer.

View More

Recent Blog Posts

Recent Twitter Posts